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Abstract
Molecular covariation of highly polymorphic viruses is thought to have crucial effects on viral replication and fitness.
This study employs association rule data mining of hepatitis C virus (HCV) sequences to search for specific evolutionary
covariation and then tests functional relevance on HCV replication. Data mining is performed between nucleotides in
the untranslated regions 59 and 39UTR, and the amino acid residues in the non-structural proteins NS2, NS3 and NS5B.
Results indicate covariance of the 243
rd nucleotide of the 59UTR with the 14
th,4 1
st,7 6
th, 110
th, 211
th and 212
th residues
of NS2 and with the 71
st,1 7 5
th and 621
st residues of NS3. Real-time experiments using an HCV subgenomic system to
quantify viral replication confirm replication regulation for each covariant pair between 59UTR243 and NS2-41, -76, -110,
-211, and NS3-71, -175. The HCV subgenomic system with/without the NS2 region shows that regulatory effects vanish
without NS2, so replicative modulation mediated by HCV 59UTR243 depends on NS2. Strong binding of the NS2 variants
to HCV RNA correlates with reduced HCV replication whereas weak binding correlates with restoration of HCV
replication efficiency, as determined by RNA-protein immunoprecipitation assay band intensity. The dominant
haplotype 59UTR243-NS2-41-76-110-211-NS3-71-175 differs according to the HCV genotype: G-Ile-Ile-Ile-Gly-Ile-Met for
genotype 1b and A-Leu-Val-Leu-Ser-Val-Leu for genotypes 1a, 2a and 2b. In conclusion, 59UTR243 co-varies with specific
NS2/3 protein amino acid residues, which may have significant structural and functional consequences for HCV
replication. This unreported mechanism involving HCV replication possibly can be exploited in the development of
advanced anti-HCV medication.
Citation: Sun H-Y, Ou N-Y, Wang S-W, Liu W-C, Cheng T-F, et al. (2011) Novel Nucleotide and Amino Acid Covariation between the 59UTR and the NS2/NS3
Proteins of Hepatitis C Virus: Bioinformatic and Functional Analyses. PLoS ONE 6(9): e25530. doi:10.1371/journal.pone.0025530
Editor: Indra Neil Sarkar, University of Vermont, United States of America
Received April 14, 2011; Accepted September 6, 2011; Published September 28, 2011
Copyright:  2011 Sun et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the National Science Council of Taiwan under grant numbers NSC 96-2628-B-006-007-MY3 and NSC 99-2320-B-006-015-
MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: t7908077@mail.ncku.edu.tw
Introduction
Co-evolution was initially defined as covarying genetic adapta-
tion between species in an environment. More recently, the
concept of covariation has been extended to covarying amino
acids at the molecular level of proteins, mostly involving the
coordinated change of certain amino acid residues in response to
the change of other amino acid residues to maintain biologically
relevant structures and functions [1]. Amino acid covariation is
commonly observed in polymorphic viruses. Such behavior may
result in compensatory mutations by which an evolving mutation
with reduced fitness can be rescued. It is well known that triple
mutations of Ile63Met, Val189Ile and Glu396Gly partially restore
the enzymatic activity of a Trp229Tyr reverse transcriptase
mutant of the human immunodeficiency virus type 1 [2]. As an
alternative example, Leu180Met and Val173Leu mutations may
enhance the replicative efficiency of a reverse transcriptase Tyr-
Met-Asp-Asp motif mutant of the hepatitis B virus [3].
Chronic hepatitis C virus (HCV) infection is a primary factor
leading to liver cirrhosis and hepatocellular carcinoma worldwide
[4]. Genomic HCV RNA consists of an open reading frame
encoding a polypeptide precursor of the sequence NH2-core-
envelope 1-envelope 2-p7- non-structural (NS) 2-NS3-NS4A-
NS4B-NS5A-NS5B-COOH, flanked by the 59 and 39 untranslated
regions (UTR). An internal ribosome entry site (IRES) within the
59UTR is essential for translational initiation of the viral RNA [5].
The cis-acting elements in the 39UTR and IRES(-) are
indispensable for the RNA replication process [6–9]. Among the
NS proteins, NS2, NS3 and NS5B perform enzymatic activities
that are necessary for the HCV life cycle [10]: (i) NS2 is a cysteine
protease responsible for autoprocessing at the NS2-NS3 junction
[11,12]; (ii) NS3 performs dual enzymatic functions as a serine
protease for the cleavage of the junctions of NS3/4A, NS4A/4B,
NS4B/5A and NS5A/5B and as a RNA helicase/NTPase for
unwinding HCV RNA [13,14]; (iii) NS5B is a RNA-dependent
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genome [15].
The highly variable HCV genome has been classified into 6
genotypes [16] which affect pathogenesis and therapeutic outcome
[17]. Covarying amino acid residues are believed to evolve for
persistent viral replication or egression, to be functionally
conserved and constrained within certain viral components.
Certain compensatory mutations at the protein level have been
reported recently [18-22]. Coordinated substitutions in NS3 and
NS4A affect HCV replication via modulation of NS5A phosphor-
ylation [19]. Compensatory mutations in p7 and NS2 restore
assembly-defective core protein mutants, whereas chimeric HCV
with coordinated mutations in envelope 1, p7, NS2, and NS3
increase the intergenotypic compatibilities for virus assembly and
release [20,22]. More importantly, amino acid covariance
networks have been identified to predict the response in HCV
patients receiving anti-viral therapy [18,21]. Such studies
underscore the significance of the functional linkage of certain
proteins and their covariant amino acid residues for HCV
persistency, raising the possibility that molecular covariation can
be computationally predicted during persistent infection for
diagnosis, prognosis and optimal drug selection.
It is suspected that covariation might involve motifs in the
UTRs which regulate HCV genome replication at transcriptional
or translational levels and may be essential for persistent HCV.
However, no studies have yet addressed covariation between the
HCV UTRs and the NS proteins. In the present study, the authors
explore the possibility that conserved covariation spots exist
between functionally essential nucleotides in the UTRs and the
amino acid residues in the 3 enzymatic NS proteins. The
association data mining algorithm in the Weka software [23]
was used to extract previously unknown and potentially meaning-
ful covariation within the HCV sequences retrieved from the Los
Alamos HCV database at the full-length genome level [24]. The
functional relevance of the observed covariation sites was then
tested in a cell-based HCV replicon system [25], analyzing the
effects of either the individual or simultaneous substitutions of
those sites with regard to replication efficiency and RNA-protein
interactive ability.
Results
Bioinformatic analysis - Preparation of 217 full-length
HCV genome sequences for association rule data mining
One of the most common applications of association rule
mining is ‘market basket’ analysis, i.e. a search is performed from
supermarket checkout data for groups of items that occur together
in transactions. A similar technique is used in this study, whereby
the nucleotides and amino acid positions are considered as
attributes in an individual instance. Association rule mining
searches for covariation rules between single nucleotides of the
UTRs and the amino acid residues of the NS proteins. To this
end, 217 full-length HCV genome sequences were downloaded
from the Los Alamos HCV sequence database on Nov. 30, 2006.
Analysis of the phylogenetic relationships of the HCV sequences
indicated that most were clustered into 4 major genotypes, 1a, 1b,
2a and 2b, while the others sporadically presented as 14 minor
genotypes (Table S1 and Fig. S1). The individual UTR RNA
segments (59UTR and 39UTR) and the NS protein segments
(NS2, NS3, NS5B) from each full-length genome sequence were
retrieved and then connected to create new sequence components
(Fig. 1) for covariation analysis. These 6 binary sequence
components were input to the Weka software to determine the
covariation association between each of the nucleotide sites and
the amino acid residues. The unique association rules of these
binary sequence datasets are summarized in Table S2. Thirty-nine
unique association rules (12 for all genotypes, 11, 2, 8 and 6 for
genotypes 1a, 1b, 2a and 2b, respectively) were identified. Results
in the set for all genotypes indicate covariance of the 204
th
nucleotide of the 59UTR with 3 amino acid residues of the NS3
protein (71, 175 and 621) and the 243
rd nucleotide of the 59UTR
with 6 amino acid residues of the NS2 protein (14, 41, 76, 110, 211
and 212) and 3 amino acid residues of the NS3 protein (71, 175
and 621). Since the covariance between 59UTR243 and NS2-14,
-41, -76, -110, -211, -212 and NS3-71, -175 and -621 consists of
associations involving the largest number of multiple sites, the
functional relevance of 59UTR243 in co-variation with the residues
in the NS2 and NS3 proteins but not the other pairings was
examined in our cell-based experiments.
Figure 1. Binary HCV sequence components used for prediction of site-specific covariation between UTRs and NS proteins. Six
sequence components for data mining were created by connecting UTR nucleotide segments and amino acid segments of the enzymatic NS
proteins, including 59UTR-NS2, 59UTR-NS3, 59UTR-NS5B, NS2-39UTR, NS3-39UTR and NS5B-39UTR. The 59UTR and 39UTR contained 341 and 272
nucleotides, respectively; the NS2, NS3 and NS5B contained 217, 631 and 591 amino acid residues, respectively. White bars indicate nucleic acid
segments; black bars indicate amino acid segments.
doi:10.1371/journal.pone.0025530.g001
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nucleotide and NS2/3 amino acid residues
The data mining results showed a strong covariation relation-
ship of the 243
rd nucleotide of 59UTR to the 14
th,4 1
st,7 6
th, 110
th,
211
th and 212
th residues of NS2 and to the 71
st, 175
th and 621
st
residues of NS3 (Fig. 2). Notably, the 59UTR243G was frequently
associated with NS2-14F, -41I, -76I, -110I, -211G, -212Q, NS3-
71I, -175M and 621A, while the 59UTR243A was associated with
NS2-14L, -41L, -76V, -110L, -211S, -212K, NS3-71V, -175L and
621T. Neither C nor T was present at the 243
rd nucleotide of the
59UTR. Simultaneous change of both sites of a covariant pair, as
opposed to the change of a single site of a covariant pair, has been
hypothesized to be better for HCV replication. With this in mind,
the HCV replication consequences of the observed covariations
were tested in a cell-based system, as detailed in the following.
Cell-based functional analysis - Evaluating HCV
replication efficiency by mutation of coordinated
variations between 59UTR243 nucleotide and NS2/NS3
amino acid residues by using NS2-39 replicon
Site-specific mutations matching various of the observed
covariations were introduced in order to analyze their effects on
the replication efficiency using a transient-replication assay. We
constructed9 pairs ofvariantsinthe contextofthewild-typeNS2-39
replicon (59UTR243G), each consisting of a single amino acid
substitution at the NS2 or NS3 region and double substitutions in
combinationwith59UTR-G243A and thecorresponding amino acid
(Figs. 3A and B). Based on the normalized luciferase activities at 3
consecutive time points, the transient luciferase assays indicated that
the 9 single amino acid variants decreased replication efficiency in
the presence of 59UTR243G, but replication efficiency could be
rescued when any single variant of NS2-I41L, NS2-I76V, NS2-
I110L, NS2-G211S, NS3-I71V and NS3-M175L was combined
with 59UTR-G243A. On the contrary, the 59UTR-G243A could not
compensatethe NS2-F14L, NS2-Q212K and NS3-A621T variants.
Furthermore, different types of codon usage were introduced for
NS2-I110L (CTT and TTG) and NS2-G211S (AGC and TCA),
yielding comparable compensatory effects and indicating that
differences of codon usage at the nucleotide level may not be a
concern (Fig. 4). These results together suggest that the covariation
of 59UTR-G243A with the NS2 and NS3 proteins was most likely
due to amino acid substitution, but this was not the case for the
specific nucleotide sequences.
Dependence of NS2 protein in functional coordinated
variations between 59UTR243 and NS3
The effects of nucleotide substitution at the 59UTR243 site with
regard to HCV replication were compared for the NS2-39 or NS3-
39 replicon backbone contexts. Compared to 59UTR243Gi nt h e
NS2-39 replicon context,59UTR-G243A showeda moderate decline
inreplicationefficiency,whereas59UTR-G243Tand59UTR-G243C
showed a profound decline (Figs. 5A and B). However, 59UTR-
G243A, 59UTR-G243Ta n d5 9UTR-G243C showed no or little
influence on replication efficiency in the context of the NS3-39
replicon (Figs. 5A and B). These results indicate that the NS2
protein may be of great importance in replicative modulation
mediated by HCV 59UTR243. Further, the NS3-I71V and NS3-
M175L variants impaired HCV replication to similar levels in the
NS3-39 replicons carrying either 59UTR243Go r5 9UTR-G243A
(Fig. 6). Because 59UTR-G243A could only compensate NS3-I71V
and NS3-M175L in the presence of NS2 (Fig. 3), the results suggest
that these functional coordinated variations between 59UTR243 and
NS3 depend on the NS2 protein.
Figure 2. Frequencies of variation sites assessed from Weka. The covariation sites were predicted at the 59UTR243 nucleotide position and
their corresponding amino acid sites in HCV NS2 or NS3. Co-variation sites between the 59UTR243G (grey) and 59UTR243A (white) with the
corresponding amino acid residues (single-letter code) are shown in accumulative percentage. A frequency .10% for an amino acid residue is
presented individually. Possible NS2 co-evolving sites include the 14
th,4 1
st,7 6
th, 110
th, 211
th and 212
th residues; possible NS3 sites include the 71
st
175
th and 621
st residues.
doi:10.1371/journal.pone.0025530.g002
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expressed NS2 proteins using NS3-39 replicon
Next, we addressed the question of whether the NS2 protein
variants expressed exogenously could modulate HCV replication
activity of the HCV NS3-39replicon in the presence of
59UTR243Go r5 9UTR243A. Wild-type and variant forms of the
NS2-flag fusion protein were transfected into stable NS3-39-Feo-
59UTR243G or NS3-39-Feo-59UTR243A replicon cells, after which
the lysate luciferase activities were analyzed (Fig. 7). The results
showed that the wild-type NS2 reduced by ,10% the replication
activity of the NS3-39-Feo-59UTR243G replicon and by ,40% the
replication activity of the NS3-39-Feo-59UTR243A replicon. As
compared to the wild-type NS2, the 6 individual variant NS2
proteins substantially reduced the replication activity of the NS3-
39-Feo-59UTR243G replicon. However, the replication efficiencies
reduced by NS2-I41L, NS2-I76V, NS2-I110L and NS2-G211S
could be rescued in the NS3-39-Feo-59UTR243A replicon, but not
those reduced by NS2-F14L, NS2-Q212K (Fig. 7A). The NS2-flag
proteins were immunostained by western blot analysis, exhibiting
at levels comparable to the 7 proteins, i.e. the wild-type and the six
variants (Fig. 7B). Thus, the results of the exogenously expressed
wild-type and the variant NS2 agreed with the experiments based
on NS2 expressed as replicon NS proteins, indicating that the
compensatory effects did not depend on whether the NS2 proteins
were expressed as a separate protein or in a polyprotein.
Regulation of HCV replication by 59UTR-mediated NS2
binding to HCV RNA
To study the RNA/protein interactions, stable NS3-39-Feo-
59UTR243G or NS3-39-Feo-59UTR243A replicon cells transfected
with each of the wild-type and variant NS2-flag expression
plasmids were crosslinked at 48 hr after transfection. Immuno-
Figure 3. Transient-replication assay of NS2-39 replicons. The replicons carried either wild-type (59UTR243G) or 59UTR-G243A and 9 pairs of
variants carrying specific amino acid residues as indicated at the NS2 or NS3 regions. Huh-7 cells were transfected with 2.5 mg of replicon RNA. (A)
Luciferase activity was determined in cell lysates at 48h (stripe), 72 h (black) and 96 h (white) posttransfection. Data were normalized by the values at
4 h posttransfection and expressed as mean 6 SD (n=4). (B) HCV-RNA was quantified by real-time PCR at 96 h posttranfection. Data were normalized
by the values at 4 h posttransfection and expressed as mean 6 SD (n=3). Note that replication efficiency of replicons carrying amino acid variants
was compensated by the presence of 59UTR-G243A, indicated as compensatory pair (C) and otherwise as non-compensatory pair (N).
doi:10.1371/journal.pone.0025530.g003
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anti-flag antibody to specifically recognize HCV NS2-flag protein.
Bound RNA samples were then detected by reverse transcription-
PCR using HCV-specific primers at the 59UTR region. The
results showed that HCV-specific 242-bp product could be
detected in the NS2-F14L, NS2-I41L, NS2-I76V, NS2-I110L,
NS2-G211S and NS2-Q212K replicon cells that expressed NS3-
39-Feo-59UTR243G, but not in the wild-type NS2 transfectant
(Fig. 8A). On the other hand, the HCV-specific 242-bp product
was detected in the wild-type NS2, NS2-F14L and NS2-Q212K
replicon cells that expressed NS3-39-Feo-59UTRG243A, but could
only barely be detected in those transfected with NS2-I41L, NS2-
I76V, NS2-I110L and NS2-G211S (Fig. 8B). The stronger ability
of NS2 to bind to the HCV-RNA of the NS2 variants relative to
the wild-type HCV-RNA correlated with decreasing HCV
replication in the 59UTR243G replicon cells, as shown in Figs. 3
and 7. As the NS2/HCV-RNA binding abilities of the NS2-I41L,
NS2-I76V, NS2-I110L and NS2-G211S variants weakened in the
59UTR243A replicon cells, HCV replication levels were restored.
Together, these data indicate that 59UTR-mediated NS2 binding
to HCV RNA can regulate HCV replication.
Genotype-specific covariation patterns between
59UTR243 nucleotide and specific NS2/NS3 amino acid
residues
Analysis of the frequencies of the co-evolutionary sites in the 217
sampled HCV genome found distinct dominant sequences
between the 1b and the non-1b genotype groups (Table S3). To
confirm the genotype-specific covariation patterns, 381 additional
full-length HCV genome sequences in an updated Los Alamos
HCV sequence database were downloaded on May 19, 2009,
making a total of 598 (217 in the Nov. 30, 2006 download + 381 in
the May 19, 2009 download = 598 total) analyzed nucleotide
sequences. The combined results showed that G-Ile-Ile-Ile-Gly-Ile-
Met was predominant (appearing in 53.8% of genotype 1b but
0.0% of genotype non-1b) for genotype-1b, while A-Leu-Val-Leu-
Ser-Val-Leu was predominant (appearing in 79.1–100.0% of
genotype non-1b but 0.0% of genotype 1b) in genotypes 1a, 2a
and 2b (Table 1). These results confirmed that the initial data
mining dataset for the nucleotide and amino acid residues found in
59UTR, NS2 and NS3 co-varied in a genotype-specific manner.
Discussion
Data mining involves finding patterns or rules in large data sets.
Such patterns can be used to make predictions or form the basis of
hypotheses for future experiments [26-28]. Data mining is being
integrated into bioinformatic research [29]. In the present study,
data mining methodology found previously unnoticed nonrandom
covariance between HCV 59UTR with NS2 and NS3 proteins
from a large HCV genomic database built from patient samples.
This nonrandom association was experimentally verified to be of
functional significance to viral replication by use of a cell-based
HCV replicon system.
Protein residue covariation may suggest physical and/or
functional constraints of paired amino acid positions [30]. As
shown in previous studies, the covarying amino acid residues in the
10 HCV proteins display a scale-free network where central amino
acid substitutions connect to many other sites [18,31]. Data
mining analysis in the present study has revealed that coordinated
variations occur between the untranslated 59UTR-RNA elements
and the amino acid residues of the NS2 and NS3 proteins. UTRs
are traditionally thought to have no influence on protein coding
sequences. Accordingly, the data mining results of this study
indicating coordinated variations between the 59UTR-RNA
element and the NS2/NS3 proteins were surprising. Importantly,
the computational results were confirmed by cell-based experi-
ments using replicon replication and RNA-protein interaction
assay to have significant effect on viral replication. Therefore, this
study demonstrates a functionally significant pattern of linkage
disequilibrium involving a non-coding nucleotide (59UTR243) and
Figure 4. Transient-replication assay of NS2-39 replicons. The replicons carried different types of codon usage for NS2-I110L (CTT and TTG)
and NS2-G211S (AGC and TCA). Huh-7 cells were transfected with 2.5 mg of replicon RNA. Resulting luciferase activities were determined from equal
amounts of cell lysate harvested at 48 h (stripe), 72 h (black) and 96 h (white) posttransfection. Data were normalized by luciferase activity measured
at 4 h posttransfection and expressed as mean 6 SD (n=4). Compensatory pairs (C) are indicated as described in Fig. 3.
doi:10.1371/journal.pone.0025530.g004
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genome. The results suggest mutual communication in trans
between HCV 59UTR-RNA and individual NS2 proteins, or a
combination of NS2 and NS3 proteins, by a mechanism that
possibly involves direct binding or interaction with a common
partner from either the HCV or host factors such as cellular
protein or RNA. Strong binding of the NS2 proteins to the HCV
59UTR-RNA appears to diminish HCV replication, whereas weak
binding correlates with restoration of HCV replicative efficiency.
In cell-based systems, HCV NS2 is not an indispensable
component for replication because HCV subgenomic replicon
RNA allows replication in the absence of NS2 [32,33]. However,
the NS2 protein may modulate IRES-dependent translation, NS3
kinetics and/or NS5B replication, thus affecting HCV synthesis of
both viral RNA and proteins [34,35], and also may mediate HCV
assembly and release [36,37]. It has been reported that NS2
sequences differ between nonresponder and relapser groups in
HCV patients receiving antiviral therapy, with clinical relevance
[38]. According to NS2 topology [12], the 14
th,4 1
st and 76
th
residues are located at the first, the second and the third
transmembrane domains, respectively. The present study suggests
a novel regulatory mechanism involving NS2, whereby NS2 with a
high binding affinity for 59UTR sequences may result in reduced
HCV RNA flexibility, which in turn may compromise HCV RNA
conformational rearrangement and/or the joining of other
essential factors, resulting in less efficient HCV replication.
Figure 5. Transient-replication assay of the NS2-39 and NS3-39 replicons. The replicons each carried wild-type (59UTR243G), 59UTR-G243A,
59UTR-G243T and 59UTR-G243C. Huh-7 cells were transfected with 2.5 mg of replicon RNA. (A) Luciferase activity was determined in cell lysate at 48 h
(stripe), 72 h (black) and 96h (white) posttransfection. Data were normalized by the values at 4 h posttransfection, expressed as mean 6 SD (n=4). (B)
HCV-RNA was quantified by real-time PCR at 96 h posttranfection. Data were normalized by the values at 4 h posttransfection, expressed as mean 6
SD (n=3).
doi:10.1371/journal.pone.0025530.g005
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position between the IRES IIIc and IIId domains of the positive
strand [5,39,40] and at the IIIc’domain of the replicative strand
[41]. Both the positive- and negative-stranded domains of this
non-coding region function as host protein binding sites which
regulate translation and replication [42,43]. In previous studies
using either rabbit reticulocyte or hepatic lysates in vitro,
59UTR243A and 59UTR243G had the same IRES translation
activities [40,44,45]. Furthermore, a G-to-A change at
59UTR243 exhibited preferential translation functions in lym-
phoblastoid cell lines and primary dentritic cells [45–47],
suggesting that 59UTR243 might be a cell-specific determinant
in viral RNA translation. The present study revealed that
changes in 59UTR243 alter HCV replication, with G, A, C and T
displayed in order of decreasing activity with the NS2-39 replicon
assay. These results agree with G and A, but not with C and T at
59UTR243 in the HCV from patient samples, i.e. the HCV
sequences in patient samples show G and A, but no C and T at
the 59UTR243 site. In addition, our results indicate that HCV
59UTR243 may mutate in a genotype-specific covariant manner.
The dominant haplotype of 59UTR243-NS2-41-76-110-211-
NS3-71-175 differed among HCV 1b and non-1b genotypes.
This variance relationship could only be seen in a population
consisting of 1b and non-1b genotypes, but not in the 1b or non-
1b subpopulations alone. The distinct haplotype patterns suggest
that the genotype-1b may split from the non-1b genotypes where
fitness epistasis causes fixation of beneficial polymorphisms
within a genotypic subpopulation. The genotype-1b haplotype
was G-Ile-Ile-Ile-Gly-Ile-Met for 59UTR243, NS2-41, -76, -110,
-211, NS3-71 and -175; that of the non-1b haplotype was A-Leu-
Val-Leu-Ser-Val-Leu. It should be noted that genotype-1b had 4
Ile residues but that genotype-non-1b had none. Genotype-non-
1b had 3 Leu residues and 2 Val residues while genotype-1b had
none, suggesting that covarying substitutions differ but that the
Figure 6. Transient-replication assay of NS3-39 replicons. The replicons carried either wild-type (59UTR243G) or 59UTR-G243A and 2 pairs of
variants carrying NS3-I71V and NS3-M175L. Huh-7 cells were transfected with 2.5 mg of replicon RNA. Luciferase activity was determined in cell lysate
at 48 h (strip), 72 h (black) and 96 h (white) posttransfection. Data were normalized by the values at 4 h posttransfection, expressed as mean 6 SD
(n=4). Non-compensatory pairs (N) are indicated as described in Fig. 3.
doi:10.1371/journal.pone.0025530.g006
Figure 7. Modulation of HCV replication by exogenously
expressed NS2 protein. (A) Three micrograms of each wild-type or
variant NS2-flag expression plasmids were transfected into stable NS3-
39-Feo-59UTR243G (black bar) or NS3-39-Feo-59UTR243A (white bar)
replicon cells. Cell lysate was harvested at 48 h posttransfection and
luciferase activity was determined. Data were calculated as the ratio to
the corresponding untransfected control, expressed as mean 6 SD
(n=4). (B) Fifty micrograms of total protein from each cell lysate were
separated by 12% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and immunostained with antibodies recognizing the flag
epitope. Compensatory pairs (C) and non-compensatory pairs (N) are
indicated as in Fig. 3.
doi:10.1371/journal.pone.0025530.g007
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be conserved between genotypes 1b and non-1b. These sites may
be of significance in determining HCV functional changes
during genome evolution.
Adaptive mutations at the NS regions in cell-culture based
systems have been shown in prior work [25,48]. A recent study
further identified an adapted Gly-to-Arg mutation at the 28
th
residue of NS2 in a chimpanzee-infected JFH-1 strain [49]. This
present study reports coevoluationary sites of the NS2 and NS3
proteins in humans. Covariance of these sites during divergent
genome evolution is assumed to be advantageous to HCV
replication in vivo. It is most likely that the primary mutations
appear at residues of the NS2 and NS3 proteins, subsequently
exerting structural-dynamic pressure that induces a conformation-
al change of 59UTR243, which is located in the most conserved
region of the HCV genome.
In conclusion, the presented data mining analysis of HCV
genome sequences has indicated by both computational method-
ology and by cell-based HCV replicon assay that 59UTR243 and
specific residues of the NS2 and NS3 proteins are involved in a
previously unnoticed nucleotide and amino acid covariation,
which may be associated with genome evolution which contributes
to functional regulation of HCV replication. These results further
support the premise that data mining methodology is an effective
tool for finding useful patterns in the increasingly large database of
contemporary virus research.
Materials and Methods
Data mining analysis
The employed data mining analysis involved the following steps:
i) full-length HCV genome sequences were downloaded from the
Figure 8. Immunoprecipitation of RNA-protein assay using anti-flag antibody recognized crosslinked HCV NS2-flag protein and
replicon RNA. Stable NS3-39-Feo-59UTR243G (A) or NS3-39-Feo-59UTR243A (B) replicon cells transfected with each of the wild-type and variant NS2-
flag expression plasmids were harvested for formaldehyde-mediated crosslinking. After immunoprecipitation with anti-flag antibody, purified RNA
samples were analyzed by reverse transcription-PCR using a primer pair spanning 242 bases from the HCV 59UTR region. Total RNA samples from
mock transfected replicon cells were analyzed by reverse transcription-PCR in parallel. Band intensity quantification was performed by AlphaImage
2200 software and a representative experimental run is shown (Lab Recyclers, MD).
doi:10.1371/journal.pone.0025530.g008
Table 1. Comparison of the predominant haplotypes of 59UTR243, NS2-41, -76, -110, -211, NS3-71 and -175 among the HCV
genotypes.
HCV genotype Number of full-length HCV sequences (n=598) Haplotype of 59UTR243, NS2-41, -76, -110, -211, NS3-71 and -175
G-Ile-Ile-Ile-Gly-Ile-Met A-Leu-Val-Leu-Ser-Val-Leu
1a 218 (100%)
a 0 (0.0%) 218 (100.0%)
1b 327 (100%) 176 (53.8%) 0 (0.0%)
2a 29 (100%) 0 (0.0%) 29 (100.0%)
2b 24 (100%) 0 (0.0%) 19 (79.1%)
aNumber (percentage).
doi:10.1371/journal.pone.0025530.t001
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UTRs and the amino acid segments of the NS proteins were
retrieved and combined, creating 6 new binary sequence
components including 59UTR-NS2, 59UTR-NS3, 59UTR-
NS5B, NS2-39UTR, NS3-39UTR and NS5B-39UTR (Fig. 1); iii)
multiple sequence alignments were constructed by the CLUSTAL
W software program [50] and confirmed by visual inspection; iv)
100% conserved columns in multiple sequence alignment were
eliminated by GeneDoc to avoid false covariation signals due to
site conservation; v) the covariation relationships of the remaining
individual sites were identified by association rule mining based on
the Apriori algorithm using Weka software [23]. A format
transformation system was used to transform the output of
GeneDoc into ARFF format which is readable as Weka input.
The Apriori algorithm satisfies 2 parameters: support (also known
as coverage, proportion of instances that contain a particular code)
and confidence (also known as accuracy, proportion of instances
that it predicts correctly) to find the best association rules. In order
to capture novel covariations from highly polymorphic sites, the
support threshold was set at 0.33. In order to identify strong
associations, the minimum confidence threshold was set at 1.0,
which indicates that the identified rule is present in 100% of the
sequences.
Cell cultures
Cell monolayers of cloned human Huh7 hepatoma cell line
were grown in Dulbecco’s modified Eagle medium (HyClone,
USA) supplemented with 10% heat-inactivated fetal bovine serum
and 1% penicillin/streptomycin at 37uC in a 5% CO2
atmosphere.
Plasmid construction
The HCV replicon constructs pFK-i341-PI-Luc/NS2-39/ET
(pNS2-39 replicon) and pFK-i341-PI-Luc/NS3-39/ET (pNS3-39
replicon) for transient replication were kindly provided by
Professor R. Bartenschlager [25]. These constructs possessed the
luciferase reporter gene and the NS gene frame starting from
either NS2 or NS3 to NS5B and were used as backbone constructs
to generate co-variation mutants. G-to-A mutation in the 59UTR
and its paired NS2 or NS3 covariant mutations were introduced
into the backbone constructs by site-directed mutagenesis using
the QuickChange XL Site-Directed Mutagenesis kit (Stratagene,
USA). The mutation sites generated in the NS2 region were F14L,
I41L, I76V, I110L, G211S or Q212K; the mutation sites
generated in the NS3 region were I71V, M175L or A621T. The
oligonucleotides used for construction of replicon variants are
listed in Table S4. To facilitate stable selection of covariant
mutants, a gene fragment composed of fused firefly luciferase and
neomycin phosphotransferase genes (Feo) was used to replace the
firefly luciferase gene. The coding regions of the wild-type and the
variant NS2 were PCR amplified from the corresponding replicon
templates and subcloned into a p3XFLAG-CMV-14 expression
vector (Sigma-Aldrich, Germany). DNA sequencing was used to
verify the exact site-specific substitutions. No non-target sequence
changes were introduced.
In vitro transcription, electroporation and transient
replication assay
In vitro transcripts were prepared and transfection by electropo-
ration was carried out as described previously [25], with slight
modifications. Briefly, the replicon plasmids were prepared with a
midi-plasmid extraction kit (Qiagen, USA), linearized with AseI
and ScaI (New England Biolabs, USA), extracted with phenol and
chloroform, precipitated with ethanol and dissolved with nuclease-
free water. T7 promoter-driven in vitro transcription was
performed with purified linearized replicon DNA using MEGA-
script T7 kit (Ambion, USA) at 37uC for 2 hours. The DNA
templates were digested by adding RNase-free DNase. After
purification by RNeasy MinElute Cleanup kit (Qiagen), the
replicon RNA was precipitated with alcohol and dissolved with
nuclease-free water. RNA quantity and purity was determined by
260nm/280nm optical density measurements and agarose gel
electrophoresis.
For electroporation, monolayered Huh7 cells were trypsinized
and resuspended at a concentration of 5610
6 cells per mL in
cytomix buffer [51] containing 2 mM of ATP and 5 mM of
glutathione. Four-hundred microliters of the suspended cells were
mixed with 2.5 mg of replicon RNA and 5 mg of total RNA from
the Huh7 cells as a carrier. The cell mixture was transferred to a 4-
mm cuvette and electroporated at 1300 V for 99 msec using
electroporation equipment (ECM 830, BTX Harvard Apparatus,
USA). After incubation at room temperature for 10 minutes, the
cells were seeded into a 6-well and harvested at given time points
after transfection.
For transient replication assay, the cells were washed with 1x
PBS and lysed with 1x passive lysis buffer (Promega, USA), 120 mL
per well. Then, 20 mL of supernatant was mixed with 100 mLo f
Luciferase assay reagent (QuantiLum Recombinant Luciferase kit,
Promega) and measured in a luminometer (Lumat LB9506,
Berthold Technologies, Germany). The values of luciferase activity
in the cell lysates harvested at 4 h posttransfection were used to
normalize the transfection efficiency.
Quantitation of HCV RNA by real-time PCR
Total RNA was isolated from cells with a single-step method
modified from the acid guanidinium–thiocyanate–phenol–chloro-
form extraction procedure with REzolTM C&T reagent (Protech
Technology, Taiwan). Intracellular HCV-RNA titers were
measured quantitatively by reverse transcription coupled to real-
time PCR assay using a LightCycler instrument (Roche, Germany)
yielding a dynamic range from 800 to 100 million copies/mL [52].
Stable HCV replicon cells
At 48 h posttransfection, the Huh7 cells transfected with
plasmids carrying Feo gene were selected by 500 mg/mL G418 for
approximately 1 month to obtain stable NS3-39-Feo-59UTR243G
and NS3-39-Feo-59UTR243A replicon cells.
Antibodies and Western blot analysis
Monoclonal antibodies specific to flag tag (clone F1804) and
actin (clone MAB1501) were purchased from Sigma-Aldrich
(USA) and Chemicon (USA), respectively. Cell lysates were
electrophoresed on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred to a polyvinylidene fluoride
membrane. After blocking, the membrane was incubated with
specific primary antibody, washed with 0.05% phosphate buffer
saline-Tween 20, reacted with horseradish peroxidase-conjugated
secondary antibody and developed with Western Lighting (Perkin-
Elmer, USA).
Immunoprecipitation of RNA-protein assay
Immunoprecipitation of RNA-protein complexes was modified
from the method in [53]. Wild-type and variant NS2 expression
plasmids were transfected into stable HCV replicon cells by
lipofectamin 2000 (Invitrogen, USA). At 48 h posttransfection,
1610
6 cells were harvested by trypsinization and then crosslinked
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temperature for 30 min, followed by a quench solution (0.25 M
glycine in phosphate buffer saline). The cells were then
resuspended in RIPA buffer (50 mM Tris-HCl, pH 7.5, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.05% sodium dodecyl
sulfate, 1 mM EDTA, 150 mM NaCl) containing a cocktail of
protease inhibitors (Roche) and RNase inhibitor (Takara, Japan)
and lysed by 3 freeze–thaw cycles. After centrifugation at
12000 rpm for 15 min to remove any insoluble materials, the
clarified supernatant was collected, pre-cleared with protein G
beads not coupled with ligand but accompanied by yeast tRNA as
a nonspecific competitor, and then incubated with protein G beads
coupled with anti-flag monoclonal antibody at room temperature
for 90 min. The complex was washed with RIPA buffer,
resuspended in a solution of 50 mM Tris-HCl, pH 7.0, 5 mM
EDTA, 10 mM dithiothreitol and 1% sodium dodecyl sulfate,
then incubated at 70uC for 45 min to reverse the crosslinking. The
immunoprecipitated RNA was analyzed by reverse transcription-
PCR. Briefly, the RNA was extracted with Rezol C&T (Protech)
reagent, reversely transcribed into cDNA with Moloney murine
leukemia virus RT (Promega) and PCR amplified for 35 cycles
with a primer pair (sense primer: 59-ACTCCACCATAGAT-
CACTCC-39 and antisense primer: 59-AACACTACTCGGC-
TAGCAGT-39) spanning 242 bases from the HCV 59UTR
region.
Supporting Information
Figure S1 Neighbor-joining phylogenetic tree of the
HCV sequences. The sequences were downloaded from the
Los Alamos HCV database on Nov. 30, 2006. 217 full-length
HCV genome sequences were aligned using CLUSTAL software
and phylogenetically analyzed by the neighbor-joining method
using the molecular evolutionary genetics analysis (MEGA)
program. The constructed phylogenetic tree includes 19 sequences
for 1a genotype (&), 127 for 1b (%), 4 for 1c (m), 22 for 2a (N), 23
for 2b (#), 1 each for genotypes 2c and 2k (.), 4 each for 3a and
3b and 1 for 3k (h), 1 for 4a (g), 2 for 5a (X), 2 each for 6a and 6k
and 1 each for 6b, 6d, 6g and 6h (e).
(TIF)
Table S1 Genotypic distribution and accession num-
bers of the 217 full-length HCV genome sequences.
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Table S2 Summary of the unique association rules.
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Table S3 The frequencies (%) of co-evolutionary sites in
the sampled HCV genome sequences.
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Table S4 Oligonucleotides used for construction of
replicon variants.
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